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In several G-protein-coupled signaling systems, ligand-
induced receptor phosphorylation by specific kinases is
suggested to lead to desensitization via mechanisms in-
cluding receptor/G-protein uncoupling, receptor inter-
nalization, and receptor down-regulation. We report
here that elimination of phosphorylation of a chemoat-
tractant receptor of Dictyostelium, either by site-di-
rected substitution of the serines or by truncation of the
C-terminal cytoplasmic domain, completely prevented
agonist-induced loss of ligand binding but did not im-
pair the adaptation of several receptor-mediated re-
sponses including the activation of adenylyl and guanyl-
yl cyclases and actin polymerization. In addition, the
phosphorylation-deficient receptors were capable of
mediating chemotaxis, aggregation, and differentiation.
We propose that for chemoattractant receptors agonist-
induced phosphorylation regulates surface binding ac-
tivity but other phosphorylation-independent mecha-
nisms mediate response adaptation.
A diverse array of hormones, neurotransmitters, and envi-
ronmental stimuli are sensed by cell surface receptors that
transduce the signals to heterotrimeric G-proteins1 within the
cell (1, 2). This extensive family of receptors shares a number of
structural and functional features (3). All of the members con-
tain seven transmembrane domains that undergo conformation
changes upon ligand binding, revealing G-protein coupling do-
mains in the cytoplasmic loops of the receptors. In this acti-
vated state, these receptors promote the exchange of GDP
bound to heterotrimeric G-proteins with GTP and, thereby,
initiate downstream signaling.
Termination of this signaling is critical in order for cells to
respond to graded stimuli. The GTPase activity of the G-pro-
tein, assisted in some instances by RGS proteins (regulators of
G-protein signaling), terminates the response once the excita-
tory input from the receptor is removed. In addition, multiple
desensitization mechanisms exist that serve to attenuate re-
sponses despite persistent stimulation (4). First, there is a
rapid functional uncoupling of these receptors from G-proteins.
Second, the ability of receptors to bind ligand can be dimin-
ished due to modulation of their affinity (5) or to becoming
inaccessible through “sequestration” or internalization. Last,
prolonged exposure to ligand leads to an actual reduction of
receptor levels (down-regulation), the consequence of acceler-
ated degradation and/or diminished transcription. In the case
of b-adrenergic receptors and rhodopsin, uncoupling is attrib-
uted to receptor phosphorylation on cytoplasmic C-terminal
domain serines/threonines by G-protein-coupled receptor ki-
nases, followed by the stoichiometric association of the phos-
phoreceptors with arrestins (6). This receptor kinase/arrestin
paradigm, however, may not be the only means for response
termination as other points in the pathway could be regulated
to effect adaptation.
The social amoebae Dictyostelium discoideum provides an
excellent model system for genetic analysis of G-protein-cou-
pled receptors (7). Starvation initiates a developmental pro-
gram in which thousands of free living amoebae aggregate and
differentiate to form a multicellular structure containing
spores. A family of four sequentially expressed G-protein-cou-
pled cAMP receptors (cARs) are essential at distinct stages in
development. cAR1 mediates three principal physiological re-
sponses during aggregation including chemotaxis, cell-to-cell
relay of the cAMP signal, and regulation of gene expression (8).
The activation of heterotrimeric G-proteins by cAR1 and the
sequence of events following this activation are highly analo-
gous to those occurring in mammalian cells.
Many cAR1-mediated responses exhibit adaptation (9). For
example, receptor-mediated activation of adenylyl cyclase
reaches a peak in 1 min and then subsides within 5–10 min
despite continued stimulation. When the stimulus is removed,
the cells regain sensitivity with a half-time of a few minutes.
cAMP-induced cell shape changes, actin polymerization, cGMP
synthesis, and myosin heavy and light chain phosphorylations
also adapt in a similar fashion. However, the kinetics of these
responses differ from one another, suggesting the involvement
of multiple independent adaptation processes. The require-
ment for pulses of extracellular cAMP to induce expression of a
number of genes during aggregation suggests that the mecha-
nism by which cAR1 regulates gene expression is also subject to
adaptation.
Adaptation of many of these responses is closely correlated
with cAR1 phosphorylation (10). Increments in stimuli aug-
ment cAR1 phosphorylation, which reaches a steady-state level
as the responses subside. When the stimulus is removed, the
extent of phosphorylation declines and, concomitantly, the cells
regain sensitivity. Saturating stimuli result in the modification
of 3 to 4 serines in the C-terminal cytoplasmic domain of the
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receptor (11). Phosphorylation of either Ser-303 or Ser-304
results in a discrete shift in cAR1’s electrophoretic mobility and
is highly correlated with an agonist-induced decrease in the
receptor’s affinity (12).
In the present study, we sought to determine the role of the
agonist-induced cAR1 phosphorylation in adaptation of several
chemoattractant-mediated processes in vivo. Our results have
led us to the unexpected conclusion that phosphorylation of
cAR1 is not essential for the termination of any of the responses
we tested, including agonist-induced adenylyl cyclase activa-
tion, actin polymerization, chemotaxis, and gene expression.
Therefore, there must be a novel phosphorylation-independent
adaptation mechanism (or mechanisms) that attenuate these
responses.
EXPERIMENTAL PROCEDURES
Generation of cAR1 Mutants—cAR1 mutant cm1234, generated by
site-directed mutagenesis as described previously (13), lacks all 18
serines of the C-terminal cytoplasmic domain. In brief, the 10 serines in
clusters 1, 2, and 4 (as defined in Ref. 13) were substituted with either
glycine or alanine. The 8 serines of cluster 3 and an intervening leucine
were deleted. A second mutant, T289, created by exonuclease III-medi-
ated deletion of a cAR1 cDNA, is truncated after Leu-289, eliminating
most of the C-terminal domain including all of its serine residues. Its
new C terminus includes the vector-encoded peptide GEEFD. Both
mutant cDNAs were subcloned into the G418-selectable, extrachromo-
somal expression vector pJK1 (14).
Generation, Growth, and Development of Cell Lines Expressing cAR1
Mutants—A car12/car32 cell line, designated RI9, was derived from
JB4 cells (15) in two steps. Each of two cAR1 loci in JB4 cells is, in part,
replaced with a selectable PYR5–6 gene fragment. First, both PYR5–6
fragments were eliminated by homologous recombination using an in-
ternally deleted cAR1 fragment (i.e. the predecessor of pMC25; Ref. 15),
yielding the car12 uracil auxotroph, JB5. Finally, cAR3 was disrupted
in JB5 cells to yield RI9 cells using the prototrophy-restoring construct
5cAR3ura as described previously (16). All homologous recombination
events were confirmed by Southern analysis.
Receptor expression constructs from above were introduced into RI9
cells by electroporation. Clonal transformants were selected for and
maintained in HL5 medium (17) supplemented with G418 (20 mg/ml).
Unless noted otherwise, experiments were conducted with cells grown
in a shaken suspension to 5 3 106 cells/ml, washed with DB (5 mM
KH2PO4, 5 mM Na2HPO4, 2 mM MgSO4, 0.2 mM CaCl2), and developed
(i.e. starved) for 5 h at 2 3 107 cells/ml of DB with shaking (120 rpm)
and pulsatile cAMP addition (50–100 nM) every 6 min.
In Vivo 32P-Labeling and Immunoblotting of cAR1 Mutants—Devel-
oped cells expressing wild-type and mutant receptors were labeled for
40 min with carrier-free 32Pi as described previously (13). Where indi-
cated, cells were stimulated with 1 mM cAMP in the presence of 10 mM
DTT for the final 10 min. Labeled cells were extracted for 5 min with
ice-cold 1% CHAPS in ERB (13) and centrifuged at 4 °C for 10 min at
10,000 rpm in a Sorvall SS-34 rotor. After two additional CHAPS
extractions, the pellets that contained cAR1 were solubilized in sample
buffer and 107 cell equivalents of each were subjected to SDS-polyacryl-
amide gel electrophoresis on a 15% “low bis” gel (0.073% w/v bis-
acrylamide). SDS-polyacrylamide gel electrophoresis-resolved proteins
were transferred to a polyvinylidene fluoride membrane and probed
with antiserum directed against the peptide sequence KREPEPER-
FEKY in the second intracellular loop of cAR1 (provided by M.
Caterina). Primary antibodies were detected using horseradish perox-
idase-conjugated donkey anti-rabbit IgG (Amersham) and chemilumi-
nescence (DuPont). Residual chemiluminescence was then quenched by
washing the blot with 0.02% sodium azide for 15 min, and autoradiog-
raphy was performed overnight to detect the 32Pi incorporated into the
receptors.
Receptor Binding Analysis—Growth-stage cells were washed with
PB (5 mM KH2PO4, 5 mM Na2HPO4), resuspended at 3 3 10
7 cells/ml in
PB containing 5 mM caffeine (to prevent spontaneous activation of
adenylyl cyclase), and shaken for 30 min at room temperature. Caf-
feine-treated cells were washed with ice-cold PB and resuspended at a
density of 108 cells/ml. cAMP binding assays were performed as de-
scribed before, separating cell bound and unbound cAMP by centrifu-
gation through oil (18). Scatchard data were analyzed using the pro-
gram LIGAND. For the loss of ligand binding measurements, caffeine-
treated and washed cells were further treated with PB alone or with 10
mM cAMP in the presence of 10 mM DTT for 15 min. The cells were then
diluted 20-fold with ice-cold PB, rapidly washed 4 times in the same
buffer, and resuspended at 108 cells/ml. Their saturable cAMP binding
was then measured with 16 nM [3H]cAMP (15).
Adenylyl Cyclase Assays—The cAMP-induced synthesis and secre-
tion of [3H]cAMP was assayed by the perfusion method previously
described (19). Vegetative amoebae were fed with [3H]adenosine-la-
beled bacteria in a shaken suspension and then allowed to develop for
5–8 h on DB agar plates. The cells were then transferred to filters,
perfused with DB with or without cAMP at a flow rate of 10 drops/min.
Effluent (1 min fractions) was collected into test tubes preloaded with
20 ml of stop solution (0.2 M HCl, 1 mM cAMP, 50 mM DTT). [3H]cAMP
was isolated by Dowex and alumina chromatography and quantitated
by scintillation counting. The adenylyl cyclase “activation trap” assay
was performed as described previously (20). Developed cells were
treated for 30 min with 5 mM caffeine and washed 4 times with ice-cold
PM (5 mM KH2PO4, 5 mM Na2HPO4, 2 mM MgSO4). The cells (8 3 10
7
cells/ml) were then stimulated at 22 °C with 10 mM cAMP and aliquots
were lysed at the indicated times. The amount of [a-32P]ATP converted
to [32P]cAMP by each lysate in 1 min was measured.
Guanylyl Cyclase Assay—cGMP accumulation resulting from guanyl-
yl cyclase activation was measured as described previously (21). Cells
were developed for 5 h, brought to a basal state by dilution and rapid
shaking (20), and then stimulated with 10 nM cAMP or 5 mM 29-deoxy-
cAMP in shaking culture at 22 °C. At designated times, aliquots of cells
were removed and lysed with perchloric acid (final 3.5%). Samples were
neutralized with KHCO3 (50% saturated at 22 °C), and the amount of
cGMP was measured by a competitive radioimmunoassay (Amersham).
Actin Polymerization—Developed cells were prepared as described
for the adenylyl cyclase activation trap assay, resuspended in PM buffer
at 3 3 107 cells/ml. Cells were kept on ice until just prior to experi-
ments, and then they were warmed to room temperature by shaking for
10 min. At time 0, 100 nM cAMP was added to stimulate cAMP-induced
actin polymerization in vivo. At the indicated times, 100-ml aliquots of
cells were combined with 1 ml of fixing solution (3.7% formaldehyde, 10
mM Pipes, 0.1% Triton X-100, 20 mM K2HPO4/KH2PO4, 5 mM EGTA, 2
mM MgCl2, 250 nM TRITC-phalloidin, pH 6.8), which served to perme-
abilize the cells, fix, and stain F-actin (22). After staining for 1 h at room
temperature, fixed cells were centrifuged (14,000 rpm, 5 min). TRITC-
phalloidin was then extracted from the pellet with methanol (1 ml) and
quantitated by fluorimetry (540-nm excitation, 575-nm emission).
Chemotaxis Assay—Chemotaxis was measured by the small popula-
tion assay (23). Cells were developed in shaking culture for 6 h with 100
nM cAMP pulses and diluted to 2 3 106 cells/ml with DB. Droplets (;0.1
ml) containing 100–200 cells were spotted with a microcapillary tube
adjacent to droplets of varying cAMP concentration on 1% agar plates
containing DB and 3 mM caffeine. After 10–20 min in a humidified
chamber, cell drops were examined for chemotaxis. Chemotactic re-
sponses were scored positive if at least twice as many amoebae were
pressed against the edge nearest the cAMP droplet compared with the
opposite edge.
RNA Isolation and Analysis—For each of the conditions, total cellu-
lar RNA was isolated from 2.5 3 107 cells as described by Nellen et al.
(24), size fractionated on 1.5% agarose gels containing 2.2 M formalde-
hyde, and transferred to nylon membranes. Northern transfers were
hybridized to [32P]dATP-labeled probes according to standard proce-
dures and exposed to x-ray film.
RESULTS
Mutants cm1234 and T289 Fail to Undergo Phosphoryla-
tion—To test the role of phosphorylation in regulation of recep-
tor function, we constructed two mutant forms of cAR1. In
cm1234, all 18 serines of the C-terminal cytoplasmic domain
were either substituted or deleted (13), whereas in T289 the
C-terminal 105 amino acid residues were deleted including all
of the serines in the cytoplasmic domain. Wild-type and mutant
receptors were expressed constitutively under the control of the
actin-15 promoter in cells lacking both cAR1 and cAR3 genes.
We elected to use car12/car32 because cAR3 mediates some
residual responses to cAMP in the absence of cAR1 (25, 26) and
appears to be dispensable (16). Thus, in this genetic back-
ground, the measured responses could be attributed entirely to
the ectopically expressed receptors. As shown in Fig. 1A, the
cells expressed relatively comparable steady-state levels of the
respective receptors. However, the expression of T289 was fre-
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quently reduced to 70% of wild-type cAR1. The molecular
weight of cm1234 is lower due to the deletion of 9 residues that
encompass one of the clusters of serines. As we have shown
previously, the cm1234 receptor does not exhibit the cAMP-
induced electrophoretic mobility shift characteristic of the wild-
type receptor. Similar results were obtained for T289, which
exhibited an apparent molecular mass of 25 kDa (Fig. 1A).
To verify that cm1234 and T289 lack phosphorylation, the
cells were metabolically labeled with [32P]orthophosphate, and
its incorporation into each receptor was assessed for both
cAMP-stimulated and unstimulated cells. Compared with wild-
type cAR1, [32P]phosphate incorporation into cm1234 or T289
was dramatically reduced; both basal and cAMP-induced phos-
phorylation were virtually undetectable (Fig. 1B).
These cell lines were used for analysis of the functional
consequences of removing phosphorylation sites. We first per-
formed Scatchard analysis on both wild-type and cm1234. As
shown in Fig. 2A, the two receptors displayed similar Kd and
Bmax values. T289 also had a similar Kd although often its Bmax
was reduced due to lower expression levels (data not shown).
Thus, any observed physiological and biochemical phenotypes
conferred by the mutant receptors cannot be attributed to
differences in the binding characteristics.
Loss of Ligand Binding Does Not Occur in the Nonphospho-
rylatable Mutants—Cells expressing wild-type cAR1 exhibit
“loss of ligand binding” in response to cAMP treatment. The
apparent loss is due to an agonist-induced reduction in the
affinity of the cell surface receptors and can be conveniently
monitored with a binding experiment at a subsaturating con-
centration of [3H]cAMP. This process is highly correlated with
phosphorylation of serine residues 303 and 304. This reduction
in affinity does not merely reflect uncoupling of the phospho-
receptor from G-protein as it occurs to a normal extent in cells
lacking the G-protein b-subunit, confirming that it is a G-
protein-independent phenomenon (Fig. 2B). As shown in Fig.
2B, the response is equally impaired for mutant receptors in
the absence of the b-subunit.
Nonphosphorylatable Receptors Are Able to Support Develop-
ment—We first examined the ability of cm1234 and T289 to
support development. As was previously shown, car12/car32
cells fail to aggregate, and normal development can be restored
by introducing a wild-type cAR1 expressed constitutively from
actin promoter (8). Remarkably, the cm1234 and T289 cells
exhibited a relatively normal progression in development to the
aggregation stage. Time-lapse video microscopy of starving cell
populations on nonnutrient agar were performed as an indirect
means of observing cAMP wave propagation. The influence of
cAMP waves on cell shape change is apparent in time-lapse
phase contrast images. Whereas waves with periodicity of 6
min were routinely observed with wild-type cells, similarly
timed “bursts” were observed near aggregation centers with
the nonphosphorylatable cells. However, these waves were
FIG. 1. In vivo phosphorylation of wild-type cAR1 and mutant
receptors. Developed cells expressing either wild-type cAR1 (wt),
cm1234, or T289 were labeled with [32P]orthophosphate. Unstimulated
(2) and cAMP-stimulated (1) samples of each were extracted with
CHAPS. The receptors, greatly enriched and quantitatively recovered
in the CHAPS-insoluble fraction, were then analyzed by SDS-polyacryl-
amide gel electrophoresis and immunoblotting with anti-cAR1 serum
and chemiluminescent detection (panel A). After quenching residual
chemiluminescence, cAR1-associated 32P was detected by autoradiog-
raphy (panel B). The position of each receptor construct is indicated
including the upshifted phosphorylated form of wild-type cAR1. A non-
specific band migrates between the two forms of wild-type cAR1 in
panel A.
FIG. 2. Ligand binding properties of the nonphosphorylatable
receptors. Panel A, Scatchard analysis of cAMP binding. Growth-stage
car12/car32 cells overexpressing either wild-type cAR1 or cm1234 were
harvested, treated with caffeine, and resuspended in phosphate buffer.
Competition of [3H]cAMP binding by unlabeled cAMP, ranging in con-
centration from 1029 M to 2 3 1026 M, was measured. Bound cAMP was
separated from unbound cAMP by pelleting the cells through silicon oil
as described previously (18). The means of triplicate determinations are
shown. Computer analysis of this data using LIGAND yielded the
following two-site models. Wild-type: Kd1 5 47 (6 11) nM; Bmax1 5 36 (6
10) 3 103 sites/cell; Kd2 5 608 (6 156) nM; Bmax2 5 365 (6 25) 3 10
3
sites/cell; cm1234: Kd1 5 30 (6 5) nM; Bmax1 5 12 (6 5) 3 10
3 sites/cell;
Kd2 5 819 (6 120) nM; Bmax2 5 292 (6 36) 3 10
3 sites/cell. Panel B, loss
of ligand binding of the mutant receptors. The receptors were expressed
in car12/car32 (open bars) and gb2 cells (solid bars). cAMP-induced
loss of ligand binding was measured as described under “Experimental
Procedures.” The reduction of binding due to cAMP pretreatment is
expressed as a percentage of the binding exhibited by buffer-treated
cells. In the experiment depicted, the buffer-treated car12/car32 cells
expressing wild-type cAR1, cm1234, and T289 bound 2300, 3000, and
1100 cpm/8 3 106 cells, respectively. The corresponding gb2 transfor-
mants bound 2600, 4000, and 1000 cpm/8 3 106 cells.
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rarely propagated as effectively as in wild type (data not
shown). This suggests that some receptor-mediated responses
may not be completely normal. In addition, when cm1234 or
T289 are overexpressed at high levels, arrest of development at
the mound stage is observed (data not shown). We are currently
investigating the cause of this phenotype. Nevertheless, as
shown in Fig. 3, the nonphosphorylatable receptors when ex-
pressed at physiological levels can mediate normal develop-
ment and produce apparently normal fruiting bodies that are
comparable to those of the wild-type cAR1 expressing control
cells.
Nonphosphorylatable Receptors Mediate Chemotaxis—The
ability to aggregate suggests that the mutant receptors are able
to mediate chemotaxis. We therefore examined the chemotaxis
of cm1234 and T289 cells toward a wide range of cAMP con-
centrations. As shown in Fig. 4, these cells were capable of
chemotaxis with a dose-response profile similar to that of cells
expressing wild-type cAR1. The EC50 for chemotaxis by the
mutant cell lines is about 2-fold higher than wild-type cells,
and at higher cAMP concentration the response by mutant
receptors declined faster than wild-type receptors. We also
carried out chemotaxis assays on a series of background cAMP
concentrations. In these assays, the cells are first placed on
agar containing a uniform concentration of attractant. After 15
min, phosphodiesterase secreted by the cells degrades cAMP
locally, and an agonist gradient extending away from the spot
of cells is established. We observed no differences in the behav-
ior of the cells expressing mutant and wild-type receptors (data
not shown). Thus, chemoattractant receptor phosphorylation
does not play a critical role in chemotaxis.
Kinetics of Chemoattractant-mediated Actin Polymerization
Are Independent of Receptor Phosphorylation—The chemotaxis
response mediated by the mutant receptors were similar to
that of wild-type receptors. However, there were subtle differ-
ences in the maximal response and the width of the dose
response curve. So we examined some of the responses closely
associated with chemotaxis such as the rapid chemoattractant-
mediated actin polymerization and activation of guanylyl cy-
clase. Actin polymerization is involved in the series of transient
cell shape changes that occur upon addition of chemoattrac-
tant. Typically filamentous actin levels rise 2–3-fold within 6 s
and then decrease to nearly base-line levels within 15 s. Con-
currently, the cells cease moving and round up. Frequently a
second, slower increase in F-actin occurs, peaking at 60–90 s,
which coincides with a spreading of the cells on the surface.
Finally, F-actin levels return to the prestimulus levels and cells
resume their prestimulus randomly motile behavior. We rea-
soned that if receptor phosphorylation was essential for adap-
tation of the F-actin response, one or more of the F-actin
changes would be delayed in the car12/car32 cells expressing
the mutant receptors. However, as illustrated in Fig. 5A, the
responses in the wild-type and mutant cells followed very sim-
ilar profiles and clearly returned to base-line levels within 5
min.
The Kinetics of Guanylyl Cyclase Activation Are Independent
of Receptor Phosphorylation—Another G-protein-coupled re-
sponse mediated by the chemoattractant receptor is transient
activation of guanylyl cyclase. As shown in Fig. 5B, stimulation
of both wild-type and cm1234 cells with 29-deoxy-cAMP pro-
duces transient activation and accumulation of cGMP. Ten
seconds after stimulation, the level of cGMP increases ten-fold
returning to the basal level after 45 s. The responses mediated
by wild-type and mutant receptors are indistinguishable, sug-
gesting that in addition to the adenylyl cyclase and actin po-
lymerization responses, the guanylyl cyclase response adapts
as well.
Kinetics of Chemoattractant-mediated Adenylyl Cyclase Ac-
tivation—The ability of the cells to aggregate also suggested
that cell-cell signaling, which depends on appropriate regula-
tion of adenylyl cyclase, is normal. To directly assess the sig-
naling response, an analysis of cAMP-induced cAMP secretion
was performed on the cm1234 and T289 cells. As previously
documented, the time-course of cAMP secretion directly re-
flects the state of activation of adenylyl cyclase. As shown in
Fig. 6A, the kinetics of secretion of cAMP from the cells ex-
pressing either the T289 or cm1234 were nearly identical to
those of cells expressing the wild-type receptor. In all cases,
cAMP elicited a transient increase in the rate of cAMP secre-
tion that peaked after 2 min and subsided after 10 min of
stimulation. In eleven similar experiments, there were no sig-
nificant differences in the rate of decline in secretion between
mutants and wild-type cells (Fig. 6A).
FIG. 3. Development of cells expressing wild-type cAR1 or mu-
tant receptors. car12/car32 cells expressing either wild-type cAR1,
cm1234, or T289 were tested for their ability to undergo development.
In addition, car12/car32 cells transformed with the empty vector,
pJK1, were also included as a control. Growth-stage cells were washed
twice with DB and plated (106 cells/cm2) on 10-cm nutrient-free plates
(1% agar in DB). After allowing cells to settle and adhere for 20 min,
excess buffer was drained, and cells were left to develop undisturbed for
2 days at room temperature. The rounded spore masses (often out of the
plane of focus) and associated stalks of fruiting bodies are apparent in
all but the vector control cells.
FIG. 4. Chemotaxis to a range of cAMP concentrations medi-
ated by wild-type or mutant receptors. The ability of car12/car32
cells expressing wild-type cAR1, cm1234, or T289 to exhibit chemotaxis
in response to a range of cAMP stimuli was examined using the small
population assay of Konijn (23). For each cAMP concentration tested,
the percentage of populations judged to have responded is plotted
versus the logarithm of the molar cAMP concentration.
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We also measured the catalytic activity of adenylyl cyclase
after cAMP stimulation in an activation trap assay. For this
assay, cells were stimulated with cAMP for varying lengths of
time and catalytic activity was measured immediately after
lysis. As shown in Fig. 6B, the profile of activation and inacti-
vation of the enzyme was indistinguishable between wild-type
cells and the mutants. We also measured the total production
of cAMP from cm1234 cells in suspension following stimulation
with 29-deoxy-cAMP, which was also transient (data not
shown). Thus, under the conditions tested, the two mutant
receptors appear to elicit kinetically identical responses. There-
fore, there must be a cAR1 phosphorylation-independent mech-
anism of adaptation for this response.
Phosphorylation Is Not Required for cAMP-dependent Gene
Expression—In addition to mediating aggregation, repeated
cAMP stimuli are required for induction of a class of genes
expressed in early aggregation. Treatment of cells with con-
stant levels of cAMP, at low or high concentrations, suppresses
expression of these genes. This requirement for pulsatile stim-
ulation suggests that the pathway that leads to expression of
these genes depends on a response that adapts. To determine
the role of cAR1 phosphorylation in this adaptation process, we
examined the induction of mRNA encoding the cell adhesion
protein, contact site A in car12/car32 cells expressing cm1234.
As was observed with the wild-type receptor, cm1234 mediated
the accumulation of contact site A mRNA in response to inter-
mittent cAMP stimuli and also repressed its expression in
response to constant cAMP (Fig. 7). The pulsatile addition of
cAMP at 6-min intervals was an effective inducer at 30, 300,
and 900 nM, whereas continuous fluxes of the nucleotide at
rates of 5, 50, and 150 nM/min all led to suppression. These
results illustrate that cAR1 phosphorylation is not necessary
for this adaptation process.
DISCUSSION
We have demonstrated that mutant receptors that cannot
undergo agonist-mediated phosphorylation can support devel-
opment of Dictyostelium. In addition, they can elicit multiple
responses including chemotaxis, activation of adenylyl and
guanylyl cyclases, and actin polymerization. Our observations
show that the tightly regulated adaptation of all of these re-
sponses does not depend on receptor phosphorylation. Thus, we
have discovered that a mechanism(s) other than receptor phos-
FIG. 5. Chemoattractant-induced actin polymerization (A) and
guanylyl cyclase activation (B). Both cAMP-induced responses were
measured in cells developed for 5 h. Panel A, car12/car32 cells express-
ing wild-type cAR1, T289, or cm1234 were stimulated with 100 nM
cAMP and 10 mM DTT. At the indicated times, aliquots of cells were
transferred to a quenching solution to simultaneously stop the reaction
and stain filamentous actin with TRITC-conjugated phalloidin. A meas-
ured amount of stimulated F-actin was normalized to the amount at the
basal state and a relative amount of polymerized actin is plotted. Panel
B, cGMP accumulation in car12/car32 cells expressing cm1234 in
response to stimulation with 5 mM 29-deoxy-cAMP and 5 mM DTT is
compared with that in wild-type AX3 cells stimulated with 10 nM cAMP.
FIG. 6. cAMP-induced adenylyl cyclase activation. The activity
of adenylyl cyclase, stimulated by either wild-type cAR1, cm1234, or
T289, was measured by two different methods. Panel A, the amount of
cAMP-stimulated [3H]cAMP secretion was measured by the perfusion
method described under “Experimental Procedures.” The time period of
stimulation of the cells with 100 nM cAMP in DB is indicated by a gray
bar. At other times, the cells were perfused with DB lacking cAMP.
Panel B, adenylyl cyclase activation trap assay (see “Experimental
Procedures”). car12/car32 cells expressing wild-type cAR1 or mutant
receptors were stimulated with 100 nM cAMP. At the indicated times,
aliquots of cells were rapidly lysed through filters, and adenylyl cyclase
activity was immediately measured in the lysates.
FIG. 7. cAMP-induced gene expression in cm1234 cells. Wild-
type cells (NC4) and car1-/car32 cells expressing cm1234 harvested
during growth phase were incubated in phosphate buffer and stimu-
lated for 6 h with different cAMP regimes as indicated in the figure.
mRNA was isolated after 0, 2, 4, and 6 h of incubation, and Northern
transfers were probed with a 32P-labeled cDNA for the contact site A
(csA) gene (a gift from A. Noegel).
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phorylation terminates multiple chemoattractant receptor-me-
diated responses.
This result was surprising in view of findings in other sys-
tems that implicate agonist-induced receptor phosphorylation
in termination of a variety of responses. In transgenic mice, a
truncated form of rhodopsin was found to mediate abnormally
prolonged hyperpolarizations, suggesting that phosphorylation
is required for the normal termination of responses to light
(27). Moreover, numerous studies have indicated a role for
b-adrenergic receptor phosphorylation in its uncoupling from
G-protein and sequestration (6, 28). In addition, Saccharomy-
ces cerevisiae cells expressing truncated pheromone receptors
exhibit heightened pheromone sensitivity (29).
Receptor phosphorylation might be expected to play a role in
background subtraction during chemotaxis. Such a mechanism
could account for the ability of wild-type cells to sense and
move up shallow gradients of chemoattractant superimposed
on a constant subsaturating level of stimulus (30). If cAR1
phosphorylation was essential for this sensitivity adjustment,
then chemotaxis mediated by the mutant receptors would be
expected to be grossly impaired. Our results show that non-
phosphorylatable mutants can mediate chemotaxis over a
broad range of agonist concentrations similar to wild-type cells.
Thus, background subtraction must be mediated by a phos-
phorylation-independent mechanism. The range of chemoat-
tractant concentrations to which the mutant receptors can
respond is narrower as shown in Fig. 3B. This may reflect their
inability to undergo the reduction of receptor affinity caused by
phosphorylation.
The putative phosphorylation-independent adaptation
mechanism required to explain our findings could theoretically
act on any site within the signal transduction pathway. Loss of
ligand binding, a rapid ligand-induced reduction in cAR1 affin-
ity, is clearly not the adaptation mechanism as cm1234 and
T289 are severely impaired in this phenomenon. Other agonist-
induced covalent modifications of the receptor or agonist-in-
duced conformational change of the receptor could act as the
phosphorylation-independent adaptation mechanism that we
uncovered. Alternatively, a cytosolic protein might compete
with the G-protein for binding to the ligand-occupied receptors.
The receptor kinase itself or an arrestin might play this role.
G2, the G-protein-coupled to cAR1, is known to be phosphoryl-
ated upon stimulation of cells with ligand (31). However, this
phosphorylation is unlikely to be the primary cause of adapta-
tion as it is transient, and the phosphorylation site in the Ga2
subunit can be eliminated without phenotypic consequence (32).
Mounting evidence suggests that a distal component in the
adenylyl cyclase pathway is a target of adaptation. GTPgS,
which can activate adenylyl cyclase in lysates of sensitive cells,
fails to do so in lysates of adapted cells (33). This is correlated
with a reduction in the ability of adapted cell membranes to
bind CRAC, a cytosolic protein essential for adenylyl cyclase
activation (34). Thus, the receptor-mediated regulation of
membrane binding sites for CRAC likely plays an important
role in adaptation of the adenylyl cyclase response. The exist-
ence of a pleckstrin homology domain in CRAC and its inability
to bind membranes of Gb null cells suggest that Gbg dimers
are a part of the binding site for CRAC and a possible target of
the regulatory modification that results in adaptation (35).
Although our findings reveal the existence of a phosphoryla-
tion-independent adaptation mechanism, they do not exclude
the possibility that this mechanism and receptor phosphoryla-
tion are functionally redundant. Our preliminary observation
that deadaptation of the adenylyl cyclase response is more
rapid in cm1234 cells than in wild-type cells is consistent with
this possibility and suggests that receptor dephosphorylation
normally limits the rate of recovery from the adapted state.
Further investigation will be required to clarify this possibility.
Could higher eukaryotic systems possess a similar phospho-
rylation-independent mechanism of adaptation? Evidence for
such a mechanism has not been observed in the studies of
rhodopsin and b-adrenergic receptors. It might possibly exist in
these systems and could have been overlooked as a result of the
in vitro approaches taken, or in the case of b-adrenergic recep-
tors, the cultured cells chosen for heterologous expression. It is
also possible that different receptors utilize different mecha-
nisms of adaptation. While rhodopsin and b-adrenergic recep-
tor-mediated responses might be regulated exclusively by re-
ceptor phosphorylation, other mammalian G-protein-coupled
receptors, such as chemokine receptors, might be regulated by
phosphorylation-independent mechanisms like those our stud-
ies have revealed in Dictyostelium.
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